TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR

TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative women’s healthcare company, today announced the acceptance of the New Drug Application (NDA) resubmission for TX-004HR, the company’s investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA) due to menopause, by the U.S. Food and … Continue reading “TherapeuticsMD Announces FDA Acceptance of New Drug Application and Prescription Drug User Fee Act (PDUFA) Date for TX-004HR”

Third Quarter of 2017 Closes with 330.7 Million Domain Name Registrations on the Internet

VeriSign, Inc. (NASDAQ: VRSN), a global leader in domain names and internet security, today announced that the third quarter of 2017 closed with approximately 330.7 million domain name registrations across all top-level domains (TLDs), a decrease of approximately 1.2 million domain name registrations as of Sept. 30, 2017.1 The decrease of approximately 1.2 million domain name … Continue reading “Third Quarter of 2017 Closes with 330.7 Million Domain Name Registrations on the Internet”

Overstock.com’s Blockchain Subsidiary tZERO Commences $250M Token Sale

tZERO is pleased to announce the long-anticipated launch of the tZERO Security Token Sale. tZERO will treat the Tokens as preferred equity in the Company. tZERO, the blockchain subsidiary of major e-retailer Overstock.com (NASDAQ:OSTK), today opened its global $250 million USD Initial Coin Offering (ICO) to accredited investors. During the period which commenced on December 18, … Continue reading “Overstock.com’s Blockchain Subsidiary tZERO Commences $250M Token Sale”

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Qudian Inc.

Robbins Geller Rudman & Dowd LLP (“Robbins Geller”) (http://www.rgrdlaw.com/cases/qudian/) today announced that a class action has been commenced on behalf of purchasers of Qudian Inc. (“Qudian”) (NYSE:QD) American Depositary Shares (“ADSs”) in or traceable to the Company’s October 18, 2017 initial public offering (“IPO”). This action was filed in the Southern District of New York and is … Continue reading “Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Qudian Inc.”

The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Qudian Inc.

The Klein Law Firm announces the commencement of an investigation of Qudian Inc. (NYSE: QD) concerning possible violations of federal securities laws. On October 17, 2017, Qudian issued 37.5 American Depositary Shares at $24 per share in its Initial Public Offering. Then on November 21, 2017, Chinese media reported that the personal information of millions of Qudian … Continue reading “The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Qudian Inc.”

Siem Helix 2 Commences Operations in Brazil

Helix Energy Solutions Group, Inc. (NYSE: HLX) announced today that the Siem Helix 2 has successfully completed the vessel acceptance process and is on contract offshore Brazil. The vessel will be performing well intervention services under a multi-year contract with Petrobras. Owen Kratz, President and Chief Executive Officer of Helix, stated, “We are pleased to announce the … Continue reading “Siem Helix 2 Commences Operations in Brazil”

Liberty Global Announces Record and Distribution Dates for Upcoming Split-Off of Latin American Division

Liberty Global plc (“Liberty Global”) (NASDAQ: LBTYA, LBTYB, LBTYK, LILA and LILAK) today announced that, in connection with the previously announced split-off of its subsidiary Liberty Latin America Ltd. (“Liberty Latin America”), which comprises Liberty Global’s operations in Latin America and the Caribbean that are currently attributed to its “LiLAC Group,” it has set a … Continue reading “Liberty Global Announces Record and Distribution Dates for Upcoming Split-Off of Latin American Division”

REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Repros Therapeutics Inc. (“Repros” or the “Company”) (NASDAQ CM: RPRX) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Allergan plc (“Allergan”) (NYSE: AGN). Under the … Continue reading “REPROS THERAPEUTICS INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout”

AltaPacific Bancorp Extends Share Repurchase Program

AltaPacific Bancorp (OTCBB:ABNK), the parent company of AltaPacific Bank, today announced that its Board of Directors has authorized an extension of the Company’s share repurchase program for an additional $4.0 million of the Company’s common stock through December 31, 2019. The Company’s repurchase program was originally announced on May 4, 2012. Since that date, the Company … Continue reading “AltaPacific Bancorp Extends Share Repurchase Program”

Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma

Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ECHELON-1 clinical trial evaluating ADCETRIS (brentuximab vedotin) as part of a frontline combination chemotherapy regimen in untreated advanced classical Hodgkin lymphoma will be presented in the Plenary Scientific Session at the 59th American Society of Hematology (ASH) annual … Continue reading “Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma”